ARCHIVES

Pfizer Begins Phase III Trial Of Sunitinib In NSCLC

This article is from The Cancer Letter archive.

Vol. 30 No. 9 | September 28, 2007

Download PDF Visit The Full Archive

Related Articles

Cediranib/Olaparib Combination Nearly Doubles PFS in Phase II

September 26, 2014

In Brief: Cancer Act Extension, Training Bill Breezing Through Congress; Army Causes Ft. Detrick Flap

July 5, 1974

FDA Policy On Support Of Medical Education Near Final Form

February 5, 1993

Reorganization Of Making Program Is Proposed

June 22, 1990

Racial Differences In Survival Increase According To Stage

August 31, 2007

Obituary: Michael Potter, 89, NIH Researcher

June 26, 2013